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1. Introduction
Deficits in prefrontal function, including working memory
(WM) functioning, are found in a number of stress-related
psychiatric disorders such as depression and posttraumatic
stress disorder (PTSD). For instance, PTSD is associated with
prefrontal dysfunction (Beckham et al., 1998; Bremner, 2002,
2006; Hou et al., 2007) and activation abnormalities in the
prefrontal cortex (PFC) during WM performance (Galletly
et al., 2001; Clark et al., 2003; Veltmeyer et al., 2005;
Moores et al., 2008). Patients with stress-related disorders
are also very susceptible to emotional distraction and poor at
suppressing trauma-related or other (emotionally arousing)
thoughts and feelings, possibly due to impaired prefrontal
functioning (McNally, 1998; Elzinga and Bremner, 2002; Wil-
liams and Moulds, 2007). The failure to reduce emotional
distraction might be associated with impairments in WM.
Specifically, WM is thought to be crucial for reducing distrac-
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Here, it is investigated whether stress hormones impair WM by reducing the ability to suppress
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(n = 21) was administered to young, healthy men, who performed a Sternberg WM task with
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encoding and recognition of the relevant stimuli for WM. Contrary to expectations, enhanced WM
performance with higher processing speed and a reduction of errors was found in the hydro-
cortisone group compared to placebo. Moreover, hydrocortisone significantly reduced the dis-
traction by emotional stimuli. These findings show that cortisol effects on WM are not
unambiguous and contrast with previous findings on the impairing effects of cortisol on WM.
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ticoids on suppression of irrelevant emotional distraction.
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tion by its capacity to maintain relevant information in mind,
and to suppress irrelevant information (Baddeley and Della,
1996; de Fockert et al., 2001; Arnsten and Li, 2005). More-
over, stress may play a role in modulating the ability to
suppress emotional distraction, since stress hormones —
specifically glucocorticoids (GCs) — have proven to impair
WM (e.g., Lupien et al., 1999). In the present study, it is
investigated whether GCs decrease the suppression of dis-
tractions.
Abundant evidence shows that memory depends on stress
hormone levels and that it is sensitive to stress exposure
(Wolf, 2003). When stressed, the hypothalamus—pituitary—
adrenal (HPA) axis is activated, leading to the release of
stress hormones that eventually enter the brain. In the brain,
GC actions are mediated by mineralocorticoid and glucocor-
ticoid receptors (GRs) in regions relevant for cognition and
memory, such as the hippocampus and the PFC (De Kloet
et al., 1998; Lupien and Lepage, 2001). GCs have found to
enhance hippocampus-dependent declarative memory con-
solidation (Buchanan and Lovallo, 2001; Cahill et al., 2003;
Kuhlmann and Wolf, 2006) and to impair memory retrieval
(de Quervain et al., 2000; Roozendaal, 2002, 2003; Kuhlmann
et al., 2005; Roozendaal et al., 2006; Buchanan et al., 2006).
Impairing effects of stress on WM performance have mainly
been ascribed to GC actions in the PFC (Lupien and Lepage,
2001). The PFC is densely packed with GRs and involved in
regulating stress-induced HPA axis activity (Diorio et al.,
1993; Lupien and Lepage, 2001; Sullivan and Gratton,
2002; Kern et al., 2008; Cerqueira et al., 2008). Both animal
and human studies have shown associations between deficits
in prefrontal cognitive functions and HPA axis dysregulations
(Mizoguchi et al., 2004; Liberzon et al., 2007). In animal
studies chronic stress was found to impair WM (Arnsten and
Goldman-Rakic, 1998; Mizoguchi et al., 2000; Arnsten, 2000;
Cerqueira et al., 2007). In humans, both chronic (Young
et al., 1999) and acute GC administration (Lupien et al.,
1999; Wolf et al., 2001) led to impaired WM. In addition,
several studies in healthy people found that acute stress-
induced GC elevations are related to impaired WM perfor-
mance (Elzinga and Roelofs, 2005; Oei et al., 2006; Schoofs
et al., 2008).
WM deficits found after stress induction or GC admin-
istration could also be a consequence of enhanced dis-
tractibility. WM is defined not only by the ability to
maintain relevant information in mind, but also by its
ability to inhibit or suppress irrelevant information. A
number of studies have shown that one of the functions
of the PFC is to keep the mind free from distracting stimuli
(Chao and Knight, 1995, 1998; Postle, 2005, 2006; D’Espo-
sito et al., 2006). In patients and monkeys with frontal
damage, WM maintenance functioning stays intact while
performing various WM tasks under conditions of low dis-
traction. For instance, monkeys with frontal lesions usually
show deficits in delayed response tasks. However, they
function well on the same task when kept in the dark
during the delay, after the presentation of stimuli, thus
free from visual distractions (D’Esposito and Postle, 1999;
Muller and Knight, 2006). Also, patients with frontal lesions
are more prone to interference, and their neurophysiolo-
gical response to irrelevant sensory stimuli is stronger
(e.g., Chao and Knight, 1995). Using functional imaging,
Gazzaley et al., 2005 demonstrated that WM impairment in
normal aging was associated with a PFC deficit in top-down
suppression of irrelevant information, while enhancement
of task-relevant activity was unimpaired. In sum, both
evidence from neuropsychological and neuroimaging stu-
dies support the idea that the PFC mediates interference
and distraction of irrelevant information during WM main-
tenance. It is therefore possible that what appears to be a
WM (maintenance) impairment induced by stress and
GCs, could also be explained by decreased suppression
of distractions.
The ability to act upon relevant information and to ignore
irrelevant info, however, is determined by the availability of
WM capacity, with high cognitive load on WM leading to more
distracter interference than low load (de Fockert et al.,
2001; see Lavie, 2005, for cognitive load theory). Consistent
with cognitive load theory, individual differences in WM
capacity have found to be related to the ability to suppress
self-relevant intrusive thought (Brewin and Smart, 2005),
vulnerability to intrusions in general, and the ability to
intentionally suppress intrusions (Schelstraete and Hupet,
2002). Interestingly, acute stress and GCs have shown to
impair WM performance particularly at high loads and not
low loads (Lupien et al., 1999; Oei et al., 2006). Stress might
make individuals especially vulnerable to distractions when
cognitive load is high.
In a few studies emotional stimuli were used to examine
effects of distraction on WM maintenance (Dolcos and
McCarthy, 2006; Dolcos et al., 2008). It is well-known that,
generally, emotional distractions are more difficult to ignore,
because emotional stimuli may be potential threats and get
prioritized processing, even under conditions of limited
attention (Windmann and Kutas, 2001; Ohman et al.,
2001). In line with this, task-irrelevant emotionally arousing
stimuli impaired WM performance to a higher degree than
neutral irrelevant distracters (Kensinger and Corkin, 2003;
Dolcos and McCarthy, 2006). It is, however, unclear how GCs
might modulate this effect. Evidence with regard to GC
effects on emotionally arousing stimuli is contradicting.
One study found that GC administration caused heightened
arousal in response to neutral stimuli without effects on
mood (Abercrombie et al., 2005), whereas one other study
found GCs to be mood uplifting (Het and Wolf, 2007). Fear-
reducing effects of GCs have also been reported. GCs were
found to diminish preconscious attention to emotionally
negative distracters (Putman et al., 2007). Also, GCs led
to a diminished startle reflex to emotional slides (Buchanan
et al., 2001). Moreover, in a clinical study, GCs reduced
phobic fear (e.g., Soravia et al., 2006). It could therefore
be argued that GC administration leads to less interference
from emotional distractions. GC administration, however,
might also lead to more interference from neutral stimuli,
if indeed these stimuli would become more arousing,
although the evidence for this option is sparse (Abercrombie
et al., 2005). Nonetheless, in both cases the distinction
between neutral and emotional distraction would be less
prominent.
In the present study, we studied the effects of a single
dose of 35 mg hydrocortisone on WM performance with neu-
tral and emotional distracters presented during the delay-
phase of an item-recognition WM task. Since stress and GCs
have shown to impair WM performance at high loads, we
hypothesized that GCs would impair overall WM performance
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especially at high loads, because of a reduced ability to
suppress distracters. However, since we used emotionally
negative and neutral distracting stimuli, we hypothesize that
the differential effects of suppressing emotional and neutral
distracters that are expected in the control group (i.e.,
slower performance when distracted by emotional stimuli
compared to neutral ones) would not appear in the experi-
mental group.
2. Methods
2.1. Participants
Male students were recruited by means of a sign-up board
and advertisements posted at the faculty of social sciences
of Leiden University. 54 participants who were part of a
larger study (see for more details Tollenaar et al., 2009)
were included and randomly assigned to an experimental
and a control group in a double blind placebo-controlled
between-subjects design. All participants were screened
before inclusion. Eligibility criteria were: a Body Mass Index
(BMI; kg/m2) between 19 and 26, and age between 18 and
35 yr. No history of disease or chronic disease requiring
medical attention, no current use of prescribed medication
or the use of remedies containing corticosteroids, no use of
psychotropic drugs, and no current and past psychiatric
problems. Volunteers were asked whether they (ever)
experienced psychological problems and/or were currently
onmedication or seeking help for psychological problems, or
whether they had been seeing a psychologist or psychiatrist
in the past. When answering ‘yes’ to any of these questions,
they were excluded. Each participant gave signed informed
consent in which confidentiality, anonymity, and the oppor-
tunity to withdraw without penalty were assured. The
hydrocortisone group received a fixed oral dose of 35 mg
of hydrocortisone. The dose of hydrocortisone used in this
study was chosen because it can be considered to simulate
endogenous physiologic secretion of cortisol under extreme
stressful situations (Kirschbaum and Hellhammer, 1989,
1994). Furthermore, the dose of hydrocortisone selected
for our trial waswithin the range used in other studies aiming
at extreme acute stress levels (e.g., Abercrombie et al.,
2003). The control group received similar looking placebo.
Characteristics of the sample were as follows (M  SD): age,
20.6  3.15 yr, range: 18—32 yr; BMI, 22.20  2.17 kg/m2;
trait anxiety (STAI-trait version), 34.07  9.25; levels of
psychopathology (symptom checklist, SCL-90),
119.12  24.17, and WM, as estimated using the Digit
Span-subtest of the Wechsler Adult Intelligence Scale
(WAIS-III, Wechsler, 1997), 10.70  2.92. No significant dif-
ferences between the two groups were found for BMI (F[1,
53] = 0.49; p = 0.49), STAI-trait (F[1, 53] = 0.07; p = 0.79),
SCL-90 (F[1, 53] = 0.09; p = 0.76), and Digit Span (F[1,
53] = 0.70, p = 0.41. The hydrocortisone group (M  SD:
21.70  3.99 yr) was older than the placebo group (M  SD:
: 19.52  1.37 yr) (F[1, 53] = 7.22; p = 0.01)1. The Medical
Ethical Committee of the Leiden University Medical Center
approved the study protocol. Participants received course
credit or a monetary compensation for taking part in the
study.
2.2. Cortisol
Cortisol was assessed via saliva samples, using Salivettes
(Sarstedt, Germany). Saliva sampling is a stress-free method
to assess unbound cortisol and a-amylase (Kirschbaum &
Hellhammer, 1994). Saliva samples were centrifuged and
stored at 20 8C until assayed at Prof Kirschbaum’s labora-
tory (http://biopsychologie.tu-dresden.de). Cortisol con-
centrations in saliva were measured using a commercially
available chemiluminescence-immuno-assay kit with high
sensitivity of 0.16 ng/ml (IBL, Hamburg, Germany). Inter-
and intra-assay coefficients of variation were below 10%.
2.3. Working memory task
Working memory was measured using an adapted version of
the Sternberg item-recognition task (Sternberg, 1966) pre-
viously used and described by Oei et al. (2006). The WM
processing load was manipulated by varying the numbers of
uppercase letters (1—4 targets) that had to be held in
memory (1000 ms) for later recognition, and by varying
the number of letters (1—4 displayed) presented in the
recognition display after a short delay (1500 ms), which
led to a load of 2, 4, 12 or 16 comparisons. For example,
if the participant had to hold four items in memory (e.g., E,
R, F and S), while searching for one of the items in a
recognition display containing four items (D, M, U, and
Z), this led to 16 possible comparisons (E—D, E—M, E—U,
E—Z, R—D, R—M, R—U, R—Z, S—D, S—M, S—U, F—D, F—M, F—
U, F—Z and S—Z). The delay-phase between target and
recognition display originally contained a fixation cross
(Lupien et al., 1999; Oei et al., 2006). In the current task
version, distracters were presented during the delay-phase
that consisted of pictures selected from the International
Affective Pictures System (Lang et al., 2001). Half of the
distracters were of negatively arousing content, e.g.,
aggressive people (M  SE: valence 2.9  1.0, arousal
5.9  0.9), the other half emotionally neutral, e.g., people
on the sidewalk (M  SE: valence 5.2  0.6, arousal
3.6  0.9) on a 9-points Likert scale, using normative ratings
for male subjects (Self-assessment Manikin, Lang, 1980).
Pictures were matched for complexity, background color,
and human or animal presence. A red fixation cross was
shown at the centre of each picture. Participants had to
ignore the distracters and press a ‘yes’ button indicating
they had recognized a target (present-target trials), or a
‘no’ button, when no target letter was recognized (absent-
target trials). Only one target letter was present in the
present-target trials. Each block consisted of 12 emotional
or neutral trials and was of low comparison load (loads 2 and
4) or high comparison loads (loads 12 and 16). It was chosen
to use both two low and two high loads to keep the test
challenging and diverse, without making it too long-lasting
and tiresome. A total of 96 trials was randomly delivered,
which lasted approximately 10 min. Stimulus presentation
software (WESP) developed at the University of Amsterdam
was used which randomizes and presents stimuli, and
records reaction times and errors.
1 This age difference was due to two participants in the hydro-
cortisone group who were 30 and 32 yrs of age, which is well below
the ‘critical’ age of 35 set for inclusion.
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2.4. Procedure
Participants arrived in the afternoon, between 1200 and
1500 h. They were seated on a chair in front of a 1700 CRT
monitor with a fixed button box on the table before them.
The first saliva sample was taken just before ingestion of the
study-medication. After pill ingestion, 75 min was spent
reading magazines and filling out questionnaires. Then, cog-
nitive tests were done for the larger study (for details on the
entire procedure see Tollenaar et al., 2009). At 115 min after
the first saliva sample, another sample was taken. Immedi-
ately hereafter, WM task instructions appeared on the com-
puter screen. The task was first explained and participants
were given the opportunity to practice the WM task in a short
practice block which consisted of 10 trials with only neutral
distracters. Furthermore, they were asked to respond as
quickly and accurately as possible. The last saliva sample
was taken at 130 min after the first sampling, just after the
WM task. An exit interview was done at the end of the larger
experiment, in which was asked whether participants
thought they had been given placebo, or one of the study-
medications.
2.5. Statistics
Reaction times were checked for errors, misses and outliers.
Errors and misses were counted and removed. Reaction times
that were smaller than 300 ms were regarded as misses.
Univariate outliers were detected using z-scores and
replaced by mean + 2 SDs of each category. Data were ana-
lyzed using repeated measures ANOVAs, with as between-
subjects factor Group (hydrocortisone vs. placebo) and Load
(high vs. low), Target type (present vs. absent) and Distracter
(emotional vs. neutral) as within-subjects factors. Green-
house-Geisser corrections were applied when the sphericity
assumption was not met. The data were analyzed using SPSS
for Windows, version 14.
3. Results
WM data of two participants (from the placebo group) were
not recorded because of a computer failure. Eight parti-
cipants (2 from the placebo group and 6 from hydrocorti-
sone group) had to be excluded from further analyses
because of extreme numbers of errors (>25%). Before
discarding these participants, the percentage of errors,
however, did not differ between groups (F(1, 51) = 0.02,
p = 0.88). A total of 21 participants in the hydrocortisone
group and 23 in the placebo group were left for further
analysis.
3.1. Cortisol
Cortisol analyses showed the expected pill-induced increase
in the hydrocortisone group, with significant effects of Time
(F[2, 84] = 94.8), Group (F[1, 42] = 121.56), and Time by
Group interaction (F[2, 84] = 113.77) (all ps < 0.0005) (see
Table 1). Participants were not able to tell whether they had
received placebo or hydrocortisone: just one participant
correctly indicated noticing an effect of hydrocortisone,
Chi-square = 4.02, df = 4, p = 0.40).
3.2. Working memory
Mean reaction times and standard errors are shown in Table 2.
The repeated measures ANOVA revealed several main
effects: first, a trend was found for the between-subjects
factor group, with shorter RTs in the hydrocortisone group
(946.74  31.39) compared to the placebo group
(1028.91  29.99), F(1, 42) = 3.58, p = 0.06. Within-sub-
jects, RTs were longer at high load (1178.54  27.59) than
at low load (797.11  18.89), F(1, 42) = 413.72, p < 0.0005.
Table 1 Cortisol levels in nmol/l.
Time Group
Placebo Hydrocortisone
M  SEM M  SEM
10 min (baseline) 9.01  0.93 7.6  0.56
+115 min (pre-test) 4.57  0.44 130.66  15.53 *
+130 min (post-test) 4.95  0.56 96.39  9.63 *
* Significant difference between groups, p < 0.0005 (unpaired
t-tests, equal variances not assumed).
Table 2 Mean (M) reaction times and standard error (SE).
Load Distracter Group
Hydrocortisone Placebo
Target: present Target: absent Target: present Target: absent
M  SE M  SE M  SE M  SE
Low Emotional 736.27  27.92 * 824.20  31.05 819.94  26.68 * 849.68  29.67
Neutral 743.74  29.17 795.03  32.56 783.06  27.87 824.97  31.11
Total 740.00  27.05 809.611  30.35 801.50  25.84 837.32  28.99
High Emotional 1051.40  45.74 * 1219.04  48.47 1192.96  43.70 * 1356.52  46.31
Neutral 1008.48  39.10 1195.77  52.54 1066.59  37.36 1337.57  50.21
Total 1029.94  38.71 1207.41  46.68 * 1129.78  36.99 1347.04  44.61 *
Total Emotional 893.84  33.15 * 1021.62  34.66 1006.45  31.67 * 1103.09  33.12
Neutral 876.11  31.85 995.39  38.41 924.83  30.44 1081.27  36.70
* Significant difference between groups, p < 0.05.
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RTs of present targets (925.31  21.36) were significantly
faster than that of absent targets (1050.35  23.90), F(1,
42) = 91.61, p < 0.0005. RTs during trials with emotional
distracters (1006.25  21.93) were longer than when neutral
distracters were shown (969.40  22.85), F(1, 42) = 11.20,
p = 0.002. Group interacted with Load, with shorter RTs at
high load in the hydrocortisone group as compared with the
placebo group, F(1, 42) = 4.01, p = 0.05. Finally, there was a
triple interaction of Target by Load by Distracter, F(1,
42) = 4.21, p = 0.046 (see Fig. 1).
Apparently, absent-target trials slopes were not differen-
tially affected by distracters, which might indicate that
another strategy was used when targets were absent, than
when targets were present, respectively, the exhaustive
search strategy vs. a self-terminating search strategy (Stern-
berg, 1969). This may possibly have abolished the sensitivity
to detect distracter interference in absent-target trials.
Moreover, absent-target trials may also have obscured (inter-
action) effects of the primary factors of interest, namely
Group, Load and Distracter. Therefore, separate analyses
were performed, splitting up the significant main effect of
target. Analysis of the reaction times on present-target trials
showed a trend for group, which indicated somewhat faster
RTs in the hydrocortisone group compared to the placebo
group (F[1, 42] = 3.56, p = 0.07). At low load, RTs were
shorter than at high load (F[1, 42] = 310.93, p < 0.0005),
and RTs were longer when distracters were emotional, than
when they were neutral (F[1, 42] = 12.60, p = 0.001). Also, a
Group by Distracter interaction was revealed, with shorter
RTs during emotional trials in the hydrocortisone group than
in the placebo group (F[1, 42] = 5.21, p = 0.028) (see Fig. 2).
A Load by Distracter interaction was found, with slower RTs in
emotional than in neutral trials at high load than at low load,
F(1, 42) = 6.70, p = 0.013 (see Fig. 1). There were no other
interactions (Fs < 1.20, ps > 0.28).
See Table 3 for means and standard errors of error rates.
Analysis of errors during present-target trials showed no
effect of Group (F[1, 42] = 1.29, p = 0.26). There were sig-
nificant main effects of Load (F[1, 42] = 48.77, p < 0.0005),
Figure 1 Load by Distracter interaction in present- and absent-
target trials.
Figure 2 Present-target trials: Group by Distracter interac-
tion.
Table 3 Mean error rates and standard errors.
Distracter Group
Hydrocortisone Placebo
Target: present Target: absent Target: present Target: absent
M  SE M  SE M  SE M  SE
Low Load Emotional 1.05 (0.20) 0.43 (0.15) 0.57 (0.20) 0.44 (0.14)
Neutral 0.76 (0.22) 0.71 (0.17) 0.57 (0.21) 0.44 (0.16)
Total 0.91 (0.16) 0.57 (0.12) 0.57 (0.15) 0.44 (0.11)
High Load Emotional 2.14 (0.38) 0.52 (0.17) 3.00 (0.37) 0.48 (0.16)
Neutral 1.52 (0.34) * 0.62 (0.20) 2.57 (0.33) * 0.70 (0.19)
Total 1.83 (0.32) * 0.57 (0.14) 2.78 (0.31) * 0.59 (0.13)
* Significant difference between groups, p < 0.05
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and Distracter (F[1, 42] = 4.66, p < 0.04), with more errors
at high load (M  SE, 2.31  0.22) than at low load (M  SE,
0.74  0.11), and more errors when distracters were neutral
(M  SE, 1.69  0.16) than when they were emotional
(M  SE, 1.35  0.15). A significant interaction was found
between Group and Load (F[1, 42] = 8.19, p < 0.007, indi-
cating that the placebo group made more errors at high load
than the hydrocortisone group (see Table 3). There were no
further significant interactions (all Fs < 1.74, all ps > 0.19).
In absent-target trials, the between-subjects factor
Group showed a trend towards faster RTs in the hydrocorti-
sone group (1008.51  33.03) than the placebo group
(1092.18  34.56), F(1, 42) = 3.06, p = 0.09. There was a
main effect of Load (F[1, 42] = 302.63, p < 0.0005), with
faster RTs at low load than at high load. There was no
significant effect of Distracter (F[1, 42] = 2.10, p = 0.16). A
Group by Load interaction (F[1, 42] = 4.60, p = 0.038) indi-
cated faster RTs in the hydrocortisone group at high load
(1207.41  35.65) compared to the placebo group
(1347.04  52.38) (see Table 2). There were no other sig-
nificant interactions (all Fs < 0.05, all ps > 0.83). A repeated
measures ANOVA on error rates showed no significant main
effects or interactions (all Fs < 1.86, all ps > 0.18).
4. Discussion
In the present study, against our expectations, the adminis-
tration of 35 mg hydrocortisone enhanced working memory
performance in healthy young men. Hydrocortisone admin-
istration tended to result in higher overall processing speed,
and its enhancing effects were specifically evident at high
load: at high load, WM performance was faster with fewer
errors. Moreover, hydrocortisone greatly reduced the distrac-
tion of emotional stimuli.
The finding that working memory performance was
enhanced after hydrocortisone administration was not in line
with our expectations. These results are inconsistent with
several studies that found WM impairments after stress and
GC administration (Lupien et al., 1999; Oei et al., 2006;
Schoofs et al., 2008). However, it is in line with the one dose—
response study that found evidence for both GC-induced WM
impairment and enhancement (Lupien et al., 1999). Lupien
et al. (1999) infused hydrocortisone (40, 300 or 600 mg/(dl/
kg)) or placebo in young healthy men and assessed WM using
the same task as was used in the present study, albeit without
distracters. They found that the highest cortisol dose
impaired WM at high comparison loads, as compared with
the 40 and 300 mg/dl-groups. Importantly, the latter two
experimental groups treated with intermediate doses per-
formed better than the placebo group at high comparison
loads. It could therefore be possible that the oral dose used in
the current study resembles the intermediate doses infused
in Lupien’s study (1999). However, comparisons between
hydrocortisone infusion, and administering a fixed oral dose
cannot easily be made and as of yet it is unknown whether
different doses — and which doses — of hydrocortisone would
result in a similar inverted U-curved association using the
emotional WM task.
Furthermore, in the present study, hydrocortisone
enhancedWM accuracy at high load during the present-target
trials. Participants were also faster, which excludes that
speed was traded off with accuracy. Different doses of
hydrocortisone administration, have, as far as we know,
not yet shown to affect WM accuracy in a Sternberg task
(Lupien et al., 1999). Accuracy has been shown to deteriorate
due to psychosocial stress (Oei et al., 2006; Schoofs et al.,
2008). Oei and colleagues found that stress impaired accu-
racy in the Sternberg paradigm specifically at high loads
during present-target trials, whereas Schoofs et al. (2008)
found group effects of stress, with decreased accuracy in the
stress group, that was most pronounced at high load using the
n-back task.
An explanation for the inconsistency between our results
and those of other studies that found WM impairment after
stress or hydrocortisone, could be the ‘time of day’ effect
(Het et al., 2005). It appears that the inverted U-curved
function between GC and memory, with very high and low GC
doses causing impairment, and moderate doses causing
enhancement, depends on the ratio of MR/GR receptor
occupancy (Lupien et al., 2002; Lupien and Lepage, 2001).
Because of the circadian cortisol peak in the morning, GC
administration would be memory impairing, whereas in the
afternoon, when basal levels are very low, GC administration
would have enhancing effects. In a meta-analysis of studies
on the effects of GC treatment on specific memory phases
(encoding, consolidation and retrieval), Het et al. (2005)
found that the effect size of GC administration was greatly
determined by the time of testing. Therefore, time of day
might modulate WM performance in a similar vein. Of the GC
treatment studies that found WM impairment, one was con-
ducted in the morning (Lupien et al., 1999) and the other in
the morning and early afternoon, i.e., 1230 h (Wolf et al.,
2001). Both studies found GC-induced WM impairment. How-
ever, as mentioned above, Lupien et al. (1999) also found WM
enhancement in their morning study, which suggests that the
effect of dose might be more important, and consequently a
better explanation for our unexpected results, than time of
day. Taken together, it cannot be ruled out that time of day
has influenced the present results, that were obtained in the
afternoon. However, more studies should first be conducted
using comparable WM tasks, and different GC doses, to be
able to draw conclusions on the effect of time of day on WM
performance.
The coactivation of the beta-adrenergic system, is
believed to be an important determinant of enhancing and
impairing effects of cortisol on declarative memory of emo-
tional material (Cahill et al., 1994; de Quervain et al., 2007).
In rats, it was shown that both lesions of the basolateral
amygdala, and propranolol administration blocked the WM
impairment induced by corticosterone (Roozendaal et al.,
2004). In line with these animal studies, WM impairment has
specifically been found during stress (Elzinga and Roelofs,
2005), or in the first part of theWM study assessed after stress
exposure (Schoofs et al., 2008), which might be associated
with the influence of concurrent adrenergic activation. How-
ever, it should be noted that using the Sternberg task we also
found WM impairment after the stressor was terminated (Oei
et al., 2006). Moreover, it is unclear to what extent adre-
nergic activation is necessary for WM impairments after GC
administration, as WM impairment after GC administration
has been found by others using neutral WM tasks (Lupien
et al., 1999; Wolf et al., 2001), which seems contradictory to
the notion that GC administration only leads to impairment
when the adrenergic system is activated. Although in the
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present study only GCs were administered, the emotionally
negative pictures that were shown during the task may have
induced some arousal. Given the fact that our results were
specific to the emotional trials, adrenergic activation may
have added to the enhancing effects on WM.
In sum, although it is unclear to what extent dose of
hydrocortisone administration, time of day or adrenergic
activation may be involved in the finding of enhanced WM
performance after hydrocortisone administration, it is unli-
kely that these factors completely explain the findings.
Probably the best alternative explanation for finding GC-
inducedWM enhancement is task-related. Our task contained
distracters, and is therefore not the same as the WM task
version used in previous studies (Lupien et al., 1999; Oei
et al., 2006; Schoofs et al., 2008; Wolf et al., 2001; Elzinga
and Roelofs, 2005). The addition of distracters has changed
the WM task significantly. It could be hypothesized therefore,
that the enhanced WM performance after hydrocortisone
administration was a direct effect of GCs on emotional
distracter suppression. Unfortunately, we did not test per-
formance on the WM task without distracters, so we cannot
disentangle whether the GC effects on (emotional) distrac-
tion were direct, or whether the effects were an indirect
consequence of enhanced WM performance. An indication,
however, that GC effects on emotional distracter were
direct, and not indirect via WM enhancement, was the
remarkable finding that GCs reduced the interference of
emotional distraction regardless of load. Overall, groups
performed slower in trials with emotional than with neutral
distracters, especially at high load. This finding is in line with
the cognitive load theory, that predicts more distracter
processing when cognitive load is high (Lavie, 2005). In
several studies that used emotional distracters this effect
was consistently present (Kensinger and Corkin, 2003; Dolcos
and McCarthy, 2006). However, in the hydrocortisone group,
interference by emotional distracters was similar to inter-
ference of neutral distracters. So, the distinction between
neutral and negatively arousing stimuli disappeared. Impor-
tantly, emotional distraction in the hydrocortisone group did
also not differ from neutral distraction in the control group.
This indicates that GCs did not heighten arousal levels of
neutral stimuli. On the contrary, the enhanced distractibility
by irrelevant emotional stimuli that generally emerges, was
greatly reduced by hydrocortisone. The fact that this was
regardless of load, might indicate that GCs directly affected
emotional distraction. This finding is consistent with other
studies that found evidence suggesting fear-reducing effects
of GC administration (Buchanan et al., 2001; Soravia et al.,
2006; Putman et al., 2007). Our data extend those findings
and may indicate that GCs decrease distractibility, particu-
larly by emotional stimuli.
GC effects on distracter interference were only found
during present-target trials. A different performance is gen-
erally found when having to detect the presence or absence
of a target (Corbin and Marquer, 2008). For present-target
trials, a self-terminating search is triggered, that is ended
when the target is encountered. For absent-target trials, an
exhaustive search strategy is displayed, where each stimulus
is examined before the search can end. It is possible that the
differential effects of emotional and neutral distracters were
masked because of the exhaustive search strategy when a
target is absent. Nevertheless, similar to present-target
trials, overall performance during absent-target trials
tended to be better in the hydrocortisone group, and was
better at high loads.
It is unclear how GCs might affect the suppression of
emotional distraction. Recently, however, Etkin et al.
(2006) proposed that interference by emotional distracters
may be overcome by an inhibitory rostral anterior cingulated
cortex (rACC)—amygdala interaction, in which the ACC
reduces the responsiveness of the amygdala toward task-
irrelevant emotional stimuli. In line with this, it was found
that conflict from non-emotional distraction is resolved by a
lateral prefrontal ‘cognitive control’ system, showing
enhanced processing in sensory cortices of task-relevant
stimuli, whereas emotional distraction was resolved by a
rACC ‘emotional control’ system, which was associated with
decreased responses to emotional stimuli in the amygdala
(Egner et al., 2008). This inhibitory relationship was also
associated with blunted autonomic responses to emotional
stimuli. Moreover, in another recent study, baseline cortisol
levels were found to modulate activity in the rACC cortices
(Liberzon et al., 2007). It could be speculated that the
present dose of hydrocortisone has strengthened the rACC
inhibitory control over the amygdala. However, this should be
studied using imaging methods, preferably using a dose—
response study.
Some limitations to our study should bementioned. First,
we have not used different doses of hydrocortisone. Without
lower and higher doses than the one used in the present
study, it remains uncertain whether different doses will give
impairing effects on WM, and specifically whether this will
be accompanied by more distracter interference. Also, we
did not assess subjective valence and arousal ratings of the
distracters. Therefore, we cannot tell whether the hydro-
cortisone group would have rated the emotionally negative
pictures as less arousing or not. Also, only males were tested
which reduces generalisation of these effects to females.
Finally, because of the relatively small sample size the
generalisability and statistical power of these data are
confined.
Here, we show for the first time in healthy men that GCs
enhance the ability to suppress interference from emotional
distractions during the implementation of a WM task. Enhan-
cing the ability to suppress intrusions is highly desirable for
patients suffering from aversive and traumatic memories.
There are several publications suggesting the possibility that
administration of GCs may be suitable for treatment (and
prevention) of PTSD and phobic fears by reducing traumatic
memory retrieval and enhancing consolidation of fear extinc-
tion memories (Aerni et al., 2004; Schelling et al., 2004;
Soravia et al., 2006; de Quervain and Margraf, 2008). Given
the present results, it could be hypothesized that GC admin-
istration enhances suppression of intrusions by decreasing
distraction by emotional stimuli directly, or indirectly by
improving WM. In a recent study, GC administration showed
to enhanceWM performance in elderly PTSD patients (Yehuda
et al., 2007). It would thus be interesting to see whether
cortisol-induced WM enhancements in PTSD patients are
related to enhanced distracter suppression. As a first step,
at our lab it is currently investigated how female PTSD
patients and healthy female controls perform on the same
task using functional imaging. Further research in a healthy
population should be done to see whether these enhancing
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effects would also arise after chronic hydrocortisone admin-
istration and whether higher or lower doses would lead to
opposite effects.
Role of funding sources
Funding of this study was provided to Marieke Tollenaar by
the Dutch Organization for Scientific Research, NWO, Grant
400-03-210. NWO had no further role in study design, collec-
tion, analysis and interpretation of the data, in the writing of
the report, nor in the decision to submit the paper for
publication.
Conflict of interest
All authors declare that they have no conflicts of interest.
Acknowledgements
We thank Dagmar Feenstra, Danielle Volker, Laura Wisse and
Liesbeth Kuiper for their help in collecting the data. We are
grateful to Peter Putman for his helpful comments on the
manuscript.
References
Abercrombie, H.C., Kalin, N.H., Thurow, M.E., Rosenkranz, M.A.,
Davidson, R.J., 2003. Cortisol variation in humans affectsmemory
for emotionally laden and neutral information. Behav. Neurosci.
117, 505—516.
Abercrombie, H.C., Kalin, N.H., Davidson, R.J., 2005. Acute cortisol
elevations cause heightened arousal ratings of objectively non-
arousing stimuli. Emotion 5, 354—359.
Aerni, A., Traber, R., Hock, C., Roozendaal, B., Schelling, G., Papas-
sotiropoulos, A., Nitsch, R.M., Schnyder, U., de Quervain, D.J.,
2004. Low-dose cortisol for symptoms of posttraumatic stress
disorder. Am. J. Psychiatry 161, 1488—1490.
Arnsten, A.F., 2000. Stress impairs prefrontal cortical function in rats
and monkeys: role of dopamine D1 and norepinephrine alpha-1
receptor mechanisms. Prog. Brain Res. 126, 183—192.
Arnsten, A.F., Goldman-Rakic, P.S., 1998. Noise stress impairs pre-
frontal cortical cognitive function in monkeys: evidence for a
hyperdopaminergic mechanism. Arch. Gen. Psychiatry 55, 362—
368.
Arnsten, A.F., Li, B.M., 2005. Neurobiology of executive functions:
catecholamine influences on prefrontal cortical functions. Biol.
Psychiatry 57, 1377—1384.
Baddeley, A., Della, S.S., 1996. Working memory and executive
control. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 351, 1397—
1403.
Beckham, J.C., Crawford, A.L., Feldman, M.E., 1998. Trail making
test performance in Vietnam combat veterans with and without
posttraumatic stress disorder. J. Trauma. Stress. 11, 811—819.
Bremner, J.D., 2006. Stress and brain atrophy. CNS. Neurol. Disord.
Drug Targets 5, 503—512.
Bremner, J.D., 2002. Neuroimaging studies in post-traumatic stress
disorder. Curr. Psychiatry Rep. 4, 254—263.
Brewin, C.R., Smart, L., 2005. Working memory capacity and sup-
pression of intrusive thoughts. J. Behav. Ther. Exp. Psychiatry 36,
61—68.
Buchanan, T.W., Brechtel, A., Sollers, J.J., Lovallo, W.R., 2001.
Exogenous cortisol exerts effects on the startle reflex indepen-
dent of emotional modulation. Pharmacol. Biochem. Behav. 68,
203—210.
Buchanan, T.W., Lovallo, W.R., 2001. Enhanced memory for emo-
tional material following stress-level cortisol treatment in
humans. Psychoneuroendocrinology 26, 307—317.
Buchanan, T.W., Tranel, D., Adolphs, R., 2006. Impaired memory
retrieval correlates with individual differences in cortisol
response but not autonomic response. Learn. Mem. 13, 382—
387.
Cahill, L., Gorski, L., Le, K., 2003. Enhanced human memory con-
solidation with post-learning stress: interaction with the degree
of arousal at encoding. Learn. Mem. 10, 270—274.
Cahill, L., Prins, B., Weber, M., McGaugh, J.L., 1994. Beta-adrenergic
activation and memory for emotional events. Nature 371, 702—
704.
Cerqueira, J.J., Almeida, O.F., Sousa, N., 2008. The stressed pre-
frontal cortex. Left? Right!. Brain Behav. Immun. 22, 630—638.
Cerqueira, J.J., Mailliet, F., Almeida, O.F., Jay, T.M., Sousa, N., 2007.
The prefrontal cortex as a key target of the maladaptive response
to stress. J. Neurosci. 27, 2781—2787.
Chao, L.L., Knight, R.T., 1995. Human prefrontal lesions increase
distractibility to irrelevant sensory inputs. Neuroreport 6, 1605—
1610.
Chao, L.L., Knight, R.T., 1998. Contribution of human prefrontal
cortex to delay performance. J. Cogn. Neurosci. 10, 167—177.
Clark, C.R., McFarlane, A.C., Morris, P., Weber, D.L., Sonkkilla, C.,
Shaw, M., Marcina, J., Tochon-Danguy, H.J., Egan, G.F., 2003.
Cerebral function in posttraumatic stress disorder during verbal
workingmemory updating: a positron emission tomography study.
Biol. Psychiatry 53, 474—481.
Corbin, L., Marquer, J., 2008. Effect of a simple experimental
control: the recall constraint in Sternberg’s memory scanning
task. Eur. J. Cogn. Psychol. 20, 913—935.
D’Esposito, M., Cooney, J.W., Gazzaley, A., Gibbs, S.E., Postle, B.R.,
2006. Is the prefrontal cortex necessary for delay task perfor-
mance? Evidence from lesion and FMRI data. J. Int. Neuropsychol.
Soc. 12, 248—260.
D’Esposito, M., Postle, B.R., 1999. The dependence of span and
delayed-response performance on prefrontal cortex. Neuropsy-
chologia 37, 1303—1315.
de Fockert, J.W., Rees, G., Frith, C.D., Lavie, N., 2001. The role of
workingmemory in visual selective attention. Science 291, 1803—
1806.
De Kloet, E.R., Vreugdenhil, E., Oitzl, M.S., Joels, M., 1998. Brain
corticosteroid receptor balance in health and disease. Endocr.
Rev. 19, 269—301.
de Quervain, D.J., Aerni, A., Roozendaal, B., 2007. Preventive effect
of beta-adrenoceptor blockade on glucocorticoid-induced mem-
ory retrieval deficits. Am. J. Psychiatry 164, 967—969.
de Quervain, D.J., Roozendaal, B., Nitsch, R.M., McGaugh, J.L.,
Hock, C., 2000. Acute cortisone administration impairs retrieval
of long-term declarative memory in humans. Nat. Neurosci. 3,
313—314.
de Quervain, D.J.F., Margraf, J., 2008. Glucocorticoids for the
treatment of post-traumatic stress disorder and phobias: a novel
therapeutic approach. Eur. J. Pharmacol. 583, 365—371.
Diorio, D., Viau, V., Meaney, M.J., 1993. The role of the medial
prefrontal cortex (cingulate gyrus) in the regulation of hyptha-
lamic—pituitary—adrenal responses to stress. J. Neurosci. 13,
3839—3847.
Dolcos, F., Diaz-Granados, P., Wang, L., McCarthy, G., 2008. Opposing
influences of emotional and non-emotional distracters upon sus-
tained prefrontal cortex activity during a delayed-response work-
ing memory task. Neuropsychologia 46, 326—335.
Dolcos, F., McCarthy, G., 2006. Brain systems mediating cognitive
interference by emotional distraction. J. Neurosci. 26, 2072—
2079.
Egner, T., Etkin, A., Gale, S., Hirsch, J., 2008. Dissociable neural
systems resolve conflict from emotional versus nonemotional
distracters. Cereb. Cortex 18, 1475—1484.
Cortisol and emotional working memory 1291
Elzinga, B.M., Bremner, J.D., 2002. Are the neural substrates of
memory the final common pathway in posttraumatic stress dis-
order (PTSD)? J. Affect. Disord. 70, 1—17.
Elzinga, B.M., Roelofs, K., 2005. Cortisol-induced impairments of
working memory require acute sympathetic activation. Behav.
Neurosci. 119, 98—103.
Etkin, A., Egner, T., Peraza, D.M., Kandel, E.R., Hirsch, J., 2006.
Resolving emotional conflict: a role for the rostral anterior
cingulate cortex in modulating activity in the amygdala. Neuron
51, 871—882.
Gazzaley, A., Cooney, J.W., Rissman, J., D’Esposito, M., 2005. Top-
down suppression deficit underlies working memory impairment
in normal aging. Nat. Neurosci. 8, 1298—1300.
Galletly, C., Clark, C.R., McFarlane, A.C.,Weber, D.L., 2001.Working
memory in posttraumatic stress disorder: an event-related poten-
tial study. J. Trauma. Stress 14, 295—309.
Het, S., Ramlov, G., Wolf, O.T., 2005. A meta-analytic review of the
effects of acute cortisol administration on human memory. Psy-
choneuroendocrinology 30, 771—784.
Het, S., Wolf, O.T., 2007. Mood changes in response to psychosocial
stress in healthy young women: effects of pretreatment with
cortisol. Behav. Neurosci. 121, 11—20.
Hou, C., Liu, J., Wang, K., Li, L., Liang, M., He, Z., Liu, Y., Zhang, Y.,
Li, W., Jiang, T., 2007. Brain responses to symptom provocation
and trauma-related short-term memory recall in coal mining
accident survivors with acute severe PTSD. Brain Res. 1144,
165—174.
Kensinger, E.A., Corkin, S., 2003. Effect of negative emotional
content on working memory and long-term memory. Emotion
3, 378—393.
Kern, S., Oakes, T.R., Stone, C.K., McAuliff, E.M., Kirschbaum, C.,
Davidson, R.J., 2008. Glucosemetabolic changes in the prefrontal
cortex are associated with HPA axis response to a psychosocial
stressor. Psychoneuroendocrinology 33, 517—529.
Kirschbaum, C., Hellhammer, D.H., 1989. Salivary cortisol in psy-
chobiological research: an overview. Neuropsychobiology 22,
150—169.
Kirschbaum, C., Hellhammer, D.H., 1994. Salivary cortisol in psy-
choneuroendocrine research: recent developments and applica-
tions. Psychoneuroendocrinology 19, 313—333.
Kuhlmann, S., Kirschbaum, C., Wolf, O.T., 2005. Effects of oral
cortisol treatment in healthy young women on memory retrieval
of negative and neutral words. Neurobiol. Learn. Mem. 83, 158—
162.
Kuhlmann, S., Wolf, O.T., 2006. Arousal and cortisol interact in
modulating memory consolidation in healthy young men. Behav.
Neurosci. 120, 217—223.
Lang, P.J., 1980. Behavioral treatment and bio-behavioral assess-
ment: computer applications. In: Sidowski, J.B., Johnson, J.H.
(Eds.),Technology in Mental Health Care Delivery Systems. Ablex,
Norwood, NJ, pp. 119—137.
Lang, P.J., Bradley, M.M., Cuthbert, B.N., 2001. International Affec-
tive Picture System (IAPS): instruction manual and affective
ratings. Technical Report A-5, The Center for Research in Psy-
chophysiology, University of Florida.
Lavie, N., 2005. Distracted and confused?: selective attention under
load. Trends Cogn. Sci. 9, 75—82.
Liberzon, I., King, A.P., Britton, J.C., Phan, K.L., Abelson, J.L.,
Taylor, S.F., 2007. Paralimbic and medial prefrontal cortical
involvement in neuroendocrine responses to traumatic stimuli.
Am. J. Psychiatry 164, 1250—1258.
Lupien, S.J., Gillin, C.J., Hauger, R.L., 1999. Working memory is
more sensitive than declarative memory to the acute effects of
corticosteroids: a dose—response study in humans. Behav. Neu-
rosci. 113, 420—430.
Lupien, S.J., Lepage, M., 2001. Stress, memory, and the hippocam-
pus: can’t live with it, can’t live without it. Behav. Brain Res. 127,
137—158.
Lupien, S.J., Wilkinson, C.W., Briere, S., Menard, C., Ng Ying Kin,
N.M., Nair, N.P., 2002. The modulatory effects of corticosteroids
on cognition: studies in young human populations. Psychoneur-
oendocrinology 27, 401—416.
McNally, R.J., 1998. Experimental approaches to cognitive abnorm-
ality in posttraumatic stress disorder. Clin. Psychol. Rev. 18, 971—
982.
Mizoguchi, K., Ishige, A., Takeda, S., Aburada, M., Tabira, T., 2004.
Endogenous glucocorticoids are essential for maintaining pre-
frontal cortical cognitive function. J. Neurosci. 24, 5492—5499.
Mizoguchi, K., Yuzurihara, M., Ishige, A., Sasaki, H., Chui, D.H.,
Tabira, T., 2000. Chronic stress induces impairment of spatial
working memory because of prefrontal dopaminergic dysfunc-
tion. J. Neurosci. 20, 1568—1574.
Moores, K.A., Clark, C.R., McFarlane, A.C., Brown, G.C., Puce, A.,
Taylor, D.J., 2008. Abnormal recruitment of working memory
updating networks during maintenance of trauma-neutral infor-
mation in post-traumatic stress disorder. Psychiatry Res. 163 (2),
156—170.
Muller, N.G., Knight, R.T., 2006. The functional neuroanatomy of
working memory: contributions of human brain lesion studies.
Neuroscience 139, 51—58.
Oei, N.Y., Everaerd, W.T., Elzinga, B.M., van Well, S., Bermond, B.,
2006. Psychosocial stress impairs working memory at high loads:
an association with cortisol levels and memory retrieval. Stress 9,
133—141.
Ohman, A., Flykt, A., Esteves, F., 2001. Emotion drives attention:
detecting the snake in the grass. J. Exp. Psychol. Gen. 130, 466—
478.
Postle, B.R., 2005. Delay-period activity in the prefrontal cortex: one
function is sensory gating. J. Cogn. Neurosci. 17, 1679—1690.
Postle, B.R., 2006. Working memory as an emergent property of the
mind and brain. Neuroscience 139, 23—38.
Putman, P., Hermans, E.J., Koppeschaar, H., van Schijndel, A., van
Honk, J., 2007. A single administration of cortisol acutely reduces
preconscious attention for fear in anxious young men. Psycho-
neuroendocrinology 32, 793—802.
Roozendaal, B., 2002. Stress and memory: opposing effects of glu-
cocorticoids on memory consolidation and memory retrieval.
Neurobiol. Learn. Mem. 78, 578—595.
Roozendaal, B., 2003. Systems mediating acute glucocorticoid
effects on memory consolidation and retrieval. Prog. Neuropsy-
chopharmacol. Biol. Psychiatry 27, 1213—1223.
Roozendaal, B., McReynolds, J.R., McGaugh, J.L., 2004. The baso-
lateral amygdala interacts with the medial prefrontal cortex in
regulating glucocorticoid effects on working memory impair-
ment. J. Neurosci. 24, 1385—1392.
Roozendaal, B., Okuda, S., de Quervain, D.J., McGaugh, J.L., 2006.
Glucocorticoids interact with emotion-induced noradrenergic
activation in influencing different memory functions. Neu-
roscience 138, 901—910.
Schelling, G., Roozendaal, B., de Quervain, D.J., 2004. Can post-
traumatic stress disorder be prevented with glucocorticoids?
Ann. N.Y. Acad. Sci. 1032, 158—166.
Schelstraete, M.A., Hupet, M., 2002. Cognitive aging and inhibitory
efficiency in the Daneman and Carpenter’s working memory task.
Exp. Aging Res. 28, 269—279.
Schoofs, D., Preuss, D., Wolf, O.T., 2008. Psychosocial stress induces
working memory impairments in an n-back paradigm. Psycho-
neuroendocrinology 33, 643—653.
Soravia, L.M., Heinrichs, M., Aerni, A., Maroni, C., Schelling, G.,
Ehlert, U., Roozendaal, B., de Quervain, D.J., 2006. Glucocorti-
coids reduce phobic fear in humans. Proc. Natl. Acad. Sci. U.S.A.
103 (14), 5585—5590.
Sternberg, S., 1966. High-speed scanning in human memory. Science
153, 652—654.
Sternberg, S., 1969. Memory-scanning: mental processes revealed by
reaction-time experiments. Am. Sci. 57, 421—457.
1292 N.Y.L. Oei et al.
Sullivan, R.M., Gratton, A., 2002. Prefrontal cortical regulation of
hypothalamic-pituitary—adrenal function in the rat and implica-
tions for psychopathology: side matters. Psychoneuroendocrinol-
ogy 27, 99—114.
Tollenaar, M.S., Elzinga, B.M., Spinhoven, P., Everaerd, W., 2009.
Immediate and prolonged effects of cortisol, but not propranolol,
on memory retrieval in healthy young men. Neurobiol. Learn.
Mem. 91, 23—31.
Veltmeyer, M.D., Clark, C.R., McFarlane, A.C., Felmingham, K.L.,
Bryant, R.A., Gordon, E., 2005. Integrative assessment of brain
and cognitive function in post-traumatic stress disorder. J. Integr.
Neurosci. 4, 145—159.
Wechsler, D., 1997. WAIS-III Administration and Scoring Manual. The
Psychological Corporation, San Antonio, TX.
Williams, A.D., Moulds, M.L., 2007. An investigation of the cognitive
and experiential features of intrusive memories in depression.
Memory 15, 912—920.
Windmann, S., Kutas, M., 2001. Electrophysiological correlates of
emotion-induced recognition bias. J. Cogn. Neurosci. 13, 577—
592.
Wolf, O.T., 2003. HPA axis and memory. Best. Pract. Res. Clin.
Endocrinol. Metab. 17, 287—299.
Wolf, O.T., Convit, A., McHugh, P.F., Kandil, E., Thorn, E.L., de Santi,
S., McEwen, B.S., de Leon, M.J., 2001. Cortisol differentially
affects memory in young and elderly men. Behav. Neurosci. 115,
1002—1011.
Yehuda, R., Harvey, P.D., Buchsbaum, M., Tischler, L., Schmeidler, J.,
2007. Enhanced effects of cortisol administration on episodic and
working memory in aging veterans with PTSD. Neuropsychophar-
macology 32, 2581—2591.
Young, A.H., Sahakian, B.J., Robbins, T.W., Cowen, P.J., 1999. The
effects of chronic administration of hydrocortisone on cognitive
function in normal male volunteers. Psychopharmacology (Berl.)
145, 260—266.
Cortisol and emotional working memory 1293
